Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand name in India. The company offers range of specialties, including cardiac, dental, neuro, oncological, orthopedic, renal, reproductive, and robotic sciences, as well as gastroenterology and hepatology, heart and lung transplant, organ transplantation, mother and childcare, and pediatrics services. It focuses on accident, biochemistry, anesthesiology, bariatric surgery, andrology and infertility, arthroscopy, Alzheimer's, bone, joint center specialties, and others. In addition, the company provides medical procedures for aneurysm, ankle arthritis and total ankle replacement, anterior cervical discectomy and fusion surgery, anterior resection, aortic aneurysm, aortic stent graft, aortic valve replacement, arthroscopy, atrial septal defect, bariatric surgery, and others. Krishna Institute of Medical Sciences Limited was incorporated in 1973 and is based in Secunderabad, India.

Revenue projections:

Revenue projections for KIMS
Revenue projections for KIMS

Krishna Institute of Medical Sciences Limited is projected to see a decline in revenue compared to last year, which could lead to investor caution. A drop in earnings is often viewed as a negative signal for profitability, making it more difficult for the company to maintain investor confidence in its financial health.

Financial Ratios:

currentRatio 0.719000
forwardPE 50.717876
debtToEquity 123.719000
earningsGrowth -0.377000
revenueGrowth 0.236000
grossMargins 0.593850
operatingMargins 0.143540
trailingEps 8.410000
forwardEps 11.170000

With KIMS's forward PE ratio being elevated, the stock may see limited price appreciation and face correction risks. It's essential to assess this metric alongside other fundamentals to determine the sustainability of the stock's current valuation.
Krishna Institute of Medical Sciences Limited's elevated debt-to-equity ratio suggests the company is highly leveraged, meaning it has significant debt compared to equity. This can be risky, particularly if Krishna Institute of Medical Sciences Limited's cash flow or profits decrease, making it harder to meet debt obligations.
KIMS's low growth in both earnings and revenue indicates potential profit shrinkage. This downward trend could be a sign of weakening financial health, signaling challenges for the company's future profitability.
KIMS's negative gross and operating margins highlight potential financial struggles, as the company is not covering its production or operational expenses. This could lead to broader concerns about its ability to achieve profitability.
KIMS's forward EPS being higher than its trailing EPS suggests that the company is expected to generate stronger profits this year. This points to improving financial performance, with KIMS anticipated to deliver better earnings than it did in the prior year.

Price projections:

Price projections for KIMS
Price projections for KIMS

Over time, Krishna Institute of Medical Sciences Limited's price projections have been consistently revised lower. This suggests analysts are becoming less optimistic about the company's future prospects and are adjusting their forecasts accordingly.

Recommendation changes over time:

Recommendations trend for KIMS
Recommendations trend for KIMS


With analysts showing a buy bias for KIMS, investors may be more inclined to see the stock as an attractive investment. The favorable outlook could spur increased interest, positioning KIMS as a safe and profitable place for investors to allocate their funds and seek growth.